Nashville Biosciences adds to its leadership team
The wholly owned subsidiary of Vanderbilt University Medical Center names a Chief Financial Officer and three Vice Presidents.
Nashville Biosciences LLC (NashBio), a wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), has announced the appointment of Dan Benetz as its Chief Financial Officer (CFO) and Geoff Nilsen as Vice President and Head of Omics. The company has also promoted Curt Allen to Vice President of Sales and Wacey Richards to Vice President of Engineering.
“With their experience and expertise, these four leaders are an asset to our executive team as we continue to build out our vision to be the indispensable real-world omics resource for life sciences research and development,” said Leeland Ekstrom, Co-Founder, Chief Executive Officer, and Director of NashBio. “Our mission is to make complex healthcare data easy to use for our partners in the biopharmaceutical, diagnostics and AI industries, enabling them to bring about clinically meaningful discoveries and therapeutics that make a difference in the lives of patients.”
NashBio was created to harness the Medical Center’s extensive genomic and bioinformatics resources for drug and diagnostics discovery and development. Leveraging Vanderbilt University innovation, NashBio serves as a commercial interface between outside companies and the formidable research capabilities housed within VUMC, including BioVU®, one of the world’s most comprehensive genetic databases linked to de-identified medical records with years of longitudinal clinical data. This unique asset is one of the largest and highest quality of its kind, providing an opportunity to guide R&D activity in biotech, pharma, diagnostics, medical devices and other life sciences applications.
Like what you've read?
Forward to a friend!